New to peptides? Start with the foundations ->
What it does - plain English
TB-500 is a synthetic peptide (a tiny lab-made chain of amino acids, the building blocks of protein) based on a 7-amino-acid segment of thymosin beta-4 - a protein your body already makes that helps cells travel to injury sites and rebuild damaged tissue. It promotes angiogenesis (new blood-vessel growth in damaged tissue), reduces inflammation, and helps cells reach where they need to go to heal.
The peptide community pairs it with BPC-157 in the "Wolverine blend" - the most-discussed recovery combo on the internet. TB-500 is the cell-migration peptide. BPC-157 is the structural-repair peptide. Together they cover both halves of the healing process - at least in the animal studies.
Important caveat: human clinical trials are sparse compared with BPC-157. The animal evidence is strong. The human evidence is thin. Go in knowing the difference.
Status
A-tier for recovery stacking - by user-reported consensus within the peptide community, not by formal trial evidence. The animal data is solid across cardiac repair, soft-tissue healing, and corneal wound healing. Human RCTs (randomized controlled trials - the gold standard of evidence) barely exist for TB-500 in healthy adults.
If you're researching the Wolverine combo, TB-500 is the less-studied half. The evidence base for BPC-157 is deeper. Go in with eyes open about the gap between animal studies and human data.
Legal status
TB-500 is not FDA-approved for human use. It is also banned by WADA (the World Anti-Doping Agency - the body that sets drug rules for Olympic and professional sports). If you compete in any sport with drug testing, do not use it.
It sits in the same gray-zone "research peptide" category as BPC-157. Compounding pharmacies do dispense it via prescription in some states - most don't. The safest legal path is a doctor's prescription through a compounding pharmacy that covers it. Most people researching this topic are using the gray-zone research-vendor route instead.
Where to source
Same rules as BPC-157: COA (Certificate of Analysis - the lab report a peptide vendor should give you proving the bottle contains what they say) or no buy. Full stop.
Two paths exist. Compounding pharmacy via telehealth with a doctor's prescription is the legal route - each batch comes with a COA, the product is sterile, and you have some regulatory backstop. Research peptide vendors with third-party batch testing are the gray-zone route - the peptide may be high quality, but you have no consumer protection.
What to skip: pre-mixed "Wolverine blend" vials from gym-bro vendors with no COA and no batch testing. The mix-and-match concept isn't the problem. Zero provenance is the problem. Buy peptides one at a time, with paperwork per peptide.
Two studies worth reading
Cardiac repair - the foundational mechanism paper
Researchers showed TB-500 helps damaged adult hearts grow new heart-muscle cells in mice after injury. The study that got TB-500 onto the recovery-community radar. Evidence is in animals, not humans - but the mechanism it describes (activating dormant repair cells) is the reason the compound gets taken seriously.
Mechanism review - wound healing and angiogenesis
Crockford et al., Annals of the New York Academy of Sciences
A review covering why thymosin beta-4 - and by extension TB-500 - helps tissue heal. The two mechanisms covered: new blood-vessel growth in damaged areas (angiogenesis), and reduced inflammation at the injury site. Useful for understanding the "why" behind what users report.
Subscribe to the dispatch
The weekly Protocol One dispatch covers what's moving in peptides, GLP-1s, and longevity protocols. Broken down for normal humans.
Last reviewed · 2026·05·04 · Status reviewed weekly